Evidence map›Paper›PMID 29018991›Full record

ArticleJournal of natural medicines2018

Ellagic acid glycosides with hepatoprotective activity from traditional Tibetan medicine Potentilla anserina.

Toshio Morikawa, Katsuya Imura, Yoshinori Akagi, Osamu Muraoka, Kiyofumi Ninomiya

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of natural medicines, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. The Identification ofMolecules (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Toshio MorikawaPharmaceutical Research and Technology Institute, Kindai University, 3-4-1 Kowakae, Higashi-osaka, Osaka, 577-8502, Japan. morikawa@kindai.ac.jp.ORCID http://orcid.org/0000-0003-2794-5365
Katsuya ImuraPharmaceutical Research and Technology Institute, Kindai University, 3-4-1 Kowakae, Higashi-osaka, Osaka, 577-8502, Japan.
Yoshinori AkagiPharmaceutical Research and Technology Institute, Kindai University, 3-4-1 Kowakae, Higashi-osaka, Osaka, 577-8502, Japan.
Osamu MuraokaPharmaceutical Research and Technology Institute, Kindai University, 3-4-1 Kowakae, Higashi-osaka, Osaka, 577-8502, Japan.
Kiyofumi NinomiyaPharmaceutical Research and Technology Institute, Kindai University, 3-4-1 Kowakae, Higashi-osaka, Osaka, 577-8502, Japan.
Kindai University · JP

Funding

JSPS KAKENHI 15K08008JSPS KAKENHI 15K08009JSPS KAKENHI 16K08313MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2014-2018, Japan S1411037
6 · The paper itself

Abstract

Two new gallic acid glycosides, potentillanosides G (1) and H (2), were newly isolated from the methanol extract of the tuberous roots of Potentilla anserina (Rosaceae), together with a known compound, ellagic acid 3-O-α-L-rhamnopyranoside (3). Their structures were elucidated on the basis of chemical and physicochemical evidence. Among the constituents, potentillanoside H (2, IC

Indexed as

AcetatesAnimalsCells, CulturedCell SurvivalCytoprotectionEllagic AcidGlycosidesHepatocytesInhibitory Concentration 50Medicine, Tibetan TraditionalMethanolMiceMolecular StructurePlant ExtractsPlant RootsPotentillaAcetatesEllagic Acidethyl acetateGlycosidesMethanolPlant ExtractsSolventsEllagic acid glycosideHepatoprotective activityPotentilla anserinaPotentillanosideRosaceae

Identifiers

PMID29018991
OpenAlexW2762471405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.